PDM

Piedmont Office Realty Trust Leases Kimley-Horn Over 60,000 Square Feet in Downtown Orlando

Retrieved on: 
Wednesday, May 11, 2022
BAA2, Kimley-Horn and Associates, Inc., S&P Global Ratings, BBB, Sun Belt, GLOBE, SR, Company, NYSE, I-4, Gold, Orange Ave., Leadership in Energy and Environmental Design, Church Street, Southeast Region, PDM, REIT, Self storage

Atlanta, May 11, 2022 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. (Piedmont") (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, today announced that Kimley-Horn and Associates, Inc. (Kimley-Horn), has leased approximately 61,000 square feet at its 200 and 222 South Orange Avenue buildings in downtown Orlando through 2034.

Key Points: 
  • Atlanta, May 11, 2022 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. (Piedmont") (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, today announced that Kimley-Horn and Associates, Inc. (Kimley-Horn), has leased approximately 61,000 square feet at its 200 and 222 South Orange Avenue buildings in downtown Orlando through 2034.
  • The lease is the largest office lease signed in downtown Orlando since 2019 and will be Kimley-Horns second location with Piedmont as they also lease approximately 80,000 square feet in Piedmonts Dallas portfolio.
  • We are excited to build upon our valued relationship with Kimley-Horn at this strategic office location, said Alex Valente, Piedmonts Executive Vice President Southeast Region.
  • Piedmont Office Realty Trust, Inc. (NYSE: PDM) is an owner, manager, developer, redeveloper, and operator of high-quality, Class A office properties located primarily in the Sunbelt.

POD DIGITAL MEDIA SECURES ADVERTISING RIGHTS TO ESPAT TV PODCASTS

Retrieved on: 
Tuesday, May 10, 2022
Family, Industry, Enthusiast Gaming, CEO, Culture, PDM, Partnership, Television, Video game

NEW YORK, May 10, 2022 /PRNewswire/ -- Pod Digital Media (PDM), the first multicultural podcast agency network, announced today it has secured the exclusive rights to podcast advertising inventory from ESPAT TV, a premium gaming content provider. The partnership will allow advertisers to target esports fans across the board including multi-cultural podcasts. Pod Digital Media welcomes over fifteen podcasts such as Enthusiast Gaming.

Key Points: 
  • NEW YORK, May 10, 2022 /PRNewswire/ -- Pod Digital Media (PDM), the first multicultural podcast agency network, announced today it has secured the exclusive rights to podcast advertising inventory from ESPAT TV, a premium gaming content provider.
  • Pod Digital Media welcomes over fifteen podcasts such as Enthusiast Gaming.
  • "We are excited to partner with Pod Digital Media, to connect culture and esports fans with leading advertisers.
  • Pod Digital Media is the leader in multicultural advertising, and we chose them to handle the advertising rights of our shows because they are embedded in culture and understand our podcaster's unique needs," says Dante Simpson, ESPAT TV CEO.

Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering CLAR-121 (Testosterone + Anastrozole) for Treatment of Androgen-Mediated Autoimmune Inflammatory Mastitis

Retrieved on: 
Tuesday, May 10, 2022
COVID-19, U.S. Securities and Exchange Commission, Twitter, Woman, Orphan, GLOBE, Annual report, Food, Security (finance), Anastrozole, Testosterone, Delivery, FDA, Inflammation, Patent, Regulation of tobacco by the U.S. Food and Drug Administration, System, LinkedIn, Method, Breast disease, SEC, Solution, Breast, PDM, USPTO, Man, AR, Therapy, Pharmaceutical industry

NORTHBROOK, Ill., May 10, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for claims that cover certain methods for the treatment of autoimmune inflammatory mastitis that can be achieved by its product candidate, CLAR-121, a proprietary combination of testosterone (T) and anastrozole delivered by a subcutaneous implant.

Key Points: 
  • We are thrilled to further establish intellectual property protection for our pipeline, said Dr. Robert Dudley, President and Chief Executive Officer of Clarus.
  • We believe this notice of allowance validates the innovation behind CLAR-121 and supports this novel approach for treating androgen-mediated inflammatory breast diseases.
  • There is no known effective drug treatment for PDM, and often the only medical intervention is disfiguring surgery.
  • Clarus currently is seeking Orphan Drug Designation from the FDA for CLAR-121 for the treatment of PDM in the second quarter of 2022.

Piedmont Office Realty Trust Earns ENERGY STAR® Partner of the Year Award for Second Year in a Row

Retrieved on: 
Tuesday, May 10, 2022
BAA2, S&P Global Ratings, EPA, BBB, Carbon, Sun Belt, GLOBE, NYSE, U.S. Department of Energy, Office of Inspector General, Partnership, Organization, Environment, Industry, Fortune, Adoption, Sale, Public health, PDM, REIT, Renewable energy

We are honored to receive the 2022 ENERGY STAR Partner of the Year award again this year, said Brent Smith, Piedmonts President and Chief Executive Officer.

Key Points: 
  • We are honored to receive the 2022 ENERGY STAR Partner of the Year award again this year, said Brent Smith, Piedmonts President and Chief Executive Officer.
  • Piedmont Office Realty Trust, Inc. (NYSE: PDM) is an owner, manager, developer, redeveloper, and operator of high-quality, Class A office properties located primarily in the Sunbelt.
  • Piedmont is a 2022 ENERGY STAR Partner of the Year.
  • ENERGY STAR is the government-backed symbol for energy efficiency, providing simple, credible, and unbiased information that consumers and businesses rely on to make well-informed decisions.

Industrial AI Startup OnePredict Begins a Global Roll-out of GuardiOne Substation at 2022 IEEE PES T&D

Retrieved on: 
Thursday, May 5, 2022
Artificial intelligence in industry, Vibration, PDM, Maintenance, Algorithm, Exposition, Temperature, Turbomachinery, Diagnosis, Health status of Asian Americans, Industry, Noise, DGA, Conference, Solution, City, Transmission, IEEE, Multimedia, Video game, Medical device

SEOUL, South Korea, May 5, 2022 /PRNewswire/ -- OnePredict , a South Korean industrial AI-based facility predictive maintenance (PdM) solution company, showcased the company's brand-new product, GuardiOne Substation, at the 2022 IEEE PES T&D (Transmission & Distribution) Conference and Exposition.

Key Points: 
  • SEOUL, South Korea, May 5, 2022 /PRNewswire/ -- OnePredict , a South Korean industrial AI-based facility predictive maintenance (PdM) solution company, showcased the company's brand-new product, GuardiOne Substation, at the 2022 IEEE PES T&D (Transmission & Distribution) Conference and Exposition.
  • OnePredict is an industrial AI-based software solution startup established in 2016 based in Korea.
  • In addition, the company showcased its new product GuardiOne Substation , an Industrial AI solution that diagnoses and predicts the health status of oil-filled transformers.
  • OnePredict is growing as a global leader in industrial AI by introducing the GuardiOne solution that provides innovative facility diagnostic insights derived from high-level technology and rich industrial know-hows.

Pinnacle West Reports 2022 First-Quarter Results

Retrieved on: 
Wednesday, May 4, 2022
Energy, Environment, Nuclear, Other Energy, Utilities, COVID-19, Weather, Social conditions in Honduras, Four Corners, Mission statement, PNW, Insurance, Maintenance, Arizona Public Service, Boston Dynamics, NYSE, Public expenditure, Safety, Boston, Legislation, Pinnacle, Depreciation, Temperature, Review, Webcast, Climate change, Risk, Explosion, Electricity, Spot (franchise), Income, Efficiency, Achievement, Fire, Arizona Corporation Commission, Goal, News, Technology, Dog, PDM, APS, Growth, Water supply, Multimedia, Security (finance), Rail transport, Renewable energy, Risk management, Public utility, Agriculture, Electric power industry, Retail, Fouquieria splendens, Pinnacle West Capital, Part Two

Other major factors negatively affecting the 2022 first-quarter results were higher depreciation and amortization expense due to increased plant assets and higher income taxes.

Key Points: 
  • Other major factors negatively affecting the 2022 first-quarter results were higher depreciation and amortization expense due to increased plant assets and higher income taxes.
  • Pinnacle West invites interested parties to listen to the live webcast of managements conference call to discuss the companys 2022 first-quarter results, as well as recent developments, at noon ET (9 a.m. Arizona time) today, May 4.
  • Several factors could cause future results to differ materially from historical results, or from outcomes currently expected or sought by Pinnacle West or APS.
  • Neither Pinnacle West nor APS assumes any obligation to update these statements, even if our internal estimates change, except as required by law.

Integrate Expands Precision Demand Marketing Capabilities with Launch of Precision Social and Cross-Channel Insights

Retrieved on: 
Tuesday, May 3, 2022
IDC, Investment, Akamai Technologies, Automation, High Precision Event Timer, Twitter, Forrester, Demand, Integration, Salesforce, Microsoft, Organization, CRM, ABM, Acceleration, Digital, Facebook, Insight, Marketing, LinkedIn, Facebook Messenger, Solution, CEO, Gartner, Device file, PDM, Public relations, Sales, Pluralsight, B2B

AUSTIN, Texas, May 3, 2022 /PRNewswire-PRWeb/ -- Integrate, the leader in B2B Precision Demand Marketing (PDM) announced today at Forrester's B2B Summit North America new cross-channel capabilities with the launch of Precision Social and cross-channel Insights in the Demand Acceleration Platform. Precision Social enables the ability to activate target account lists in social, rounding out Integrate's cross-channel activation offerings, which also includes Precision Syndication, Precision Digital, and Precision Events. Data from these solutions are funneled into a new cross-channel Insights experience in Integrate's Demand Acceleration Platform. For the first time, B2B marketers have one centralized platform that brings together data from social, content syndication, digital ads, and in-person and virtual events to illuminate channel performance.

Key Points: 
  • Precision Social enables the ability to activate target account lists in social, rounding out Integrate's cross-channel activation offerings, which also includes Precision Syndication , Precision Digital , and Precision Events .
  • Data from these solutions are funneled into a new cross-channel Insights experience in Integrate's Demand Acceleration Platform.
  • Integrate's new capabilities support a cross-channel, connected and flexible Precision Demand Marketing approach.
  • Precision Social includes the following capabilities:
    Account targeting: Upload target account lists and prioritize the accounts using buyer intent data to drive Precision Social campaigns on LinkedIn.

Xcell Biosciences Appoints Shannon Eaker, Ph.D. as Chief Technology Officer

Retrieved on: 
Tuesday, May 3, 2022
Science, Stem Cells, Software, Other Science, Biotechnology, Pharmaceutical, Health, Technology, Shannon, Cell biology, Process, University, GE Healthcare, Automation, Regenerative medicine, Cell, TME, Software, Safety, HSC, IPS, ISCT, Gene, Industry, CEO, International Society, Research, PDM, Growth, Molecular biology, Multimedia, Vaccine, Pharmaceutical industry, Biochemistry

Xcell Biosciences Inc. (Xcellbio), an automation and instrumentation company focused on cell therapy manufacturing, today announced the appointment of Shannon Eaker, Ph.D., as its Chief Technology Officer.

Key Points: 
  • Xcell Biosciences Inc. (Xcellbio), an automation and instrumentation company focused on cell therapy manufacturing, today announced the appointment of Shannon Eaker, Ph.D., as its Chief Technology Officer.
  • View the full release here: https://www.businesswire.com/news/home/20220503005385/en/
    Xcellbio has appointed Shannon Eaker, Ph.D., as its Chief Technology Officer.
  • He joins Xcellbio from Cytiva (formerly GE Healthcare) Cell and Gene Therapy where he spent more than 11 years.
  • Xcellbio has made incredible progress in delivering robust, high-value cell and gene therapy development technologies to labs around the world, said Dr. Eaker.

Piedmont Office Realty Trust Reports First Quarter 2022 Results

Retrieved on: 
Wednesday, April 27, 2022
Tenant, Core, Internal Revenue Code, NYSE, U.S. Securities and Exchange Commission, S&P Global Ratings, Securities Act of 1933, Terrorism, George French Angas, LIBOR, Internal Revenue Code section 1031, Securities Exchange Act of 1934, Public health, PDM, Investment, GAAP, Public expenditure, Forward-looking statement, COVID-19, Technology, Risk, BBB, BAA2, Travel, Company, Acquisition, Annual report, Phrase, Security (finance), News, London Interbank Bid Rate, Investor relations, Net income, Sun Belt, REIT, Insurance, NAREIT, FFO, Real estate investment trust, Maintenance, Risk management, Depreciation

In addition, the Company's guidance is based on information available to management as of the date of this release.

Key Points: 
  • In addition, the Company's guidance is based on information available to management as of the date of this release.
  • Piedmont has scheduled a conference call and an audio web cast for Thursday, April 28, 2022 at 9:00 A.M. Eastern daylight time.
  • During the audio web cast and conference call, the Company's management team will review first quarter 2022 performance, discuss recent events, and conduct a question-and-answer period.
  • Piedmont Office Realty Trust, Inc. (NYSE: PDM) is an owner, manager, developer, redeveloper, and operator of high-quality, Class A office properties located primarily in the Sunbelt.

LexisNexis Risk Solutions Named a Leader in IDC MarketScape Report on U.S. Provider Data Management for Payers

Retrieved on: 
Tuesday, April 19, 2022
Diamond, Health, Data management, Government, LSE, IDC, Telecommunication, Software, ICT, Patient satisfaction, LexisNexis Risk Solutions, Payment, Health care, Technology, Insurance, Solution, General manager, RELX, PDM, Data science, Multimedia, Risk, Risk management

ATLANTA, April 19, 2022 /PRNewswire/ -- LexisNexis® Risk Solutions, the premier provider of healthcare data and identity verification solutions, has been named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2022 Vendor Assessment1. The report notes, "LexisNexis Risk Solutions' commitment to cleansed, quality provider data is outstanding and evident."

Key Points: 
  • ATLANTA, April 19, 2022 /PRNewswire/ -- LexisNexis Risk Solutions , the premier provider of healthcare data and identity verification solutions, has been named a Leader in the IDC MarketScape: U.S.
  • The report notes, "LexisNexis Risk Solutions' commitment to cleansed, quality provider data is outstanding and evident."
  • This IDC MarketScape study assesses the capability and business strategy of many of the most prominent provider data management (PDM) vendors found in payers that use that software to establish a "core provider system of record or truth" for the payer enterprise.
  • "This is indeed an impressive set of pure provider data management functionality; its approach to volume, quality, completeness, coverage, and mandate compliance is notable."